Lynch is the former National Partner in Charge of the Financial Services division at KPMG, LLC and has served as an independent director for over a decade at both American International Group, Inc., where he currently serves, and Federal Home Loan Mortgage Corp., or Freddie Mac, from which he recently retired. Lynch's appointment will become effective on August 7, 2019.
Lynch served as national partner in charge of the financial services division at KPMG, LLC from 2004 until his retirement in 2007.
Prior to that, he held a variety of positions at KPMG during his 29-year tenure, including chair of KPMG's Americas Financial Services Leadership team and a member of the global financial services Leadership and the US industries leadership teams.
He currently serves as an independent director of American International Group, Inc., a position he has held since July 2009.
From 2008 to 2019, he also served as a director of Federal Home Loan Mortgage Corp. (Freddie Mac), where he was the former Non-Executive chairman of the board.
Lynch has chaired audit committees of both AIG and Freddie Mac and has relevant committee experience on Risk, Compensation and Nomination and Corporate Governance.
Lynch is a member of the Advisory board of the Stanford Institute for Economic Policy Research and a member of the audit committee chair Advisory Council of the National Association of Corporate directors. He received a Bachelor of Science in Accounting from the University of Kansas.
Tenet Healthcare is a national diversified healthcare services company headquartered in Dallas, TX, with 110,000 employees.
Through a care network that includes United Surgical Partners International, the company operates 65 hospitals and approximately 500 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers and other outpatient facilities.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business